Corvus Pharmaceuticals (CRVS) EBIT (2015 - 2026)
Corvus Pharmaceuticals (CRVS) reported EBIT of -$19.3 million for Q2 2026, compared with -$10.26 million a year earlier.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) EBIT (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Corvus Pharmaceuticals' EBIT came in at -$55.01 million; for FY2023, it came in at -$23.41 million.
- By year, EBIT came in at -$32.57 million in FY2022, -$38.63 million in FY2021, -$43.76 million in FY2020 and -$48.85 million in FY2019.
- The Q2 2026 figure ranks as the lowest quarterly EBIT in data going back to Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Corvus Pharmaceuticals | 941.69 Mn | 430.13 Mn | - | -19.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.30 Mn |
| Mar 31, 2026 | -14.88 Mn |
| Dec 31, 2025 | -12.22 Mn |
| Sep 30, 2025 | -10.57 Mn |
| Jun 30, 2025 | -10.26 Mn |
| Mar 31, 2025 | -9.92 Mn |
| Dec 31, 2024 | -8.11 Mn |
| Sep 30, 2024 | -7.26 Mn |
| Jun 30, 2024 | -5.94 Mn |
| Mar 31, 2024 | -6.25 Mn |
| Dec 31, 2023 | -5.65 Mn |
| Sep 30, 2023 | -5.56 Mn |
| Jun 30, 2023 | -5.62 Mn |
| Mar 31, 2023 | -6.57 Mn |
| Dec 31, 2022 | -5.67 Mn |
| Sep 30, 2022 | -12.47 Mn |
| Jun 30, 2022 | -7.01 Mn |
| Mar 31, 2022 | -7.41 Mn |
| Dec 31, 2021 | -6.81 Mn |
| Sep 30, 2021 | -9.05 Mn |
API Access
Corvus Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();